TY - JOUR
T1 - First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies
AU - Namkoong, H.
AU - Asakura, T.
AU - Ishii, M.
AU - Yoda, S.
AU - Masaki, K.
AU - Sakagami, T.
AU - Iwasaki, E.
AU - Yamagishi, Y.
AU - Kanai, T.
AU - Betsuyaku, T.
AU - Hasegawa, N.
N1 - Funding Information:
Supported in part by the Japan Agency for Medical Research and Development (project 17fk0108116h0401 ).
Publisher Copyright:
© 2018 The Author(s)
PY - 2019/1
Y1 - 2019/1
N2 - This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.
AB - This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.
KW - Anti–interferon gamma (IFN-γ) autoantibody
KW - Mycobacterium aviumcomplex (MAC)
KW - disseminated Mycobacterium aviumcomplex infection
KW - hepatobiliary infection
KW - jaundice
UR - http://www.scopus.com/inward/record.url?scp=85056726089&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85056726089&partnerID=8YFLogxK
U2 - 10.1016/j.nmni.2018.10.001
DO - 10.1016/j.nmni.2018.10.001
M3 - Article
AN - SCOPUS:85056726089
SN - 2052-2975
VL - 27
SP - 4
EP - 6
JO - New Microbes and New Infections
JF - New Microbes and New Infections
ER -
